These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

360 related items for PubMed ID: 32390303

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Proliferative role of BDNF/TrkB signaling is associated with anoikis resistance in cervical cancer.
    Yuan Y, Ye HQ, Ren QC.
    Oncol Rep; 2018 Aug; 40(2):621-634. PubMed ID: 29989647
    [Abstract] [Full Text] [Related]

  • 5. Brain-derived neurotrophic factor (BDNF)-induced tropomyosin-related kinase B (Trk B) signaling is a potential therapeutic target for peritoneal carcinomatosis arising from colorectal cancer.
    Tanaka K, Okugawa Y, Toiyama Y, Inoue Y, Saigusa S, Kawamura M, Araki T, Uchida K, Mohri Y, Kusunoki M.
    PLoS One; 2014 Aug; 9(5):e96410. PubMed ID: 24801982
    [Abstract] [Full Text] [Related]

  • 6. BDNF mediated TrkB activation is a survival signal for transitional cell carcinoma cells.
    Huang YT, Lai PC, Wu CC, Hsu SH, Cheng CC, Lan YF, Chiu TH.
    Int J Oncol; 2010 Jun; 36(6):1469-76. PubMed ID: 20428771
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. miR-199b-5p-DDR1-ERK signalling axis suppresses prostate cancer metastasis via inhibiting epithelial-mesenchymal transition.
    Zhao Z, Zhao S, Luo L, Xiang Q, Zhu Z, Wang J, Liu Y, Luo J.
    Br J Cancer; 2021 Mar; 124(5):982-994. PubMed ID: 33239676
    [Abstract] [Full Text] [Related]

  • 10. Role of Tropomyosin-related kinase B receptor and brain-derived neurotrophic factor in cancer.
    Serafim Junior V, Fernandes GMM, Oliveira-Cucolo JG, Pavarino EC, Goloni-Bertollo EM.
    Cytokine; 2020 Dec; 136():155270. PubMed ID: 32911446
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. CKB inhibits epithelial-mesenchymal transition and prostate cancer progression by sequestering and inhibiting AKT activation.
    Wang Z, Hulsurkar M, Zhuo L, Xu J, Yang H, Naderinezhad S, Wang L, Zhang G, Ai N, Li L, Chang JT, Zhang S, Fazli L, Creighton CJ, Bai F, Ittmann MM, Gleave ME, Li W.
    Neoplasia; 2021 Nov; 23(11):1147-1165. PubMed ID: 34706306
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. MiR-1-3p inhibits cell proliferation and invasion by regulating BDNF-TrkB signaling pathway in bladder cancer.
    Gao L, Yan P, Guo FF, Liu HJ, Zhao ZF.
    Neoplasma; 2018 Nov; 65(1):89-96. PubMed ID: 29322793
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.